Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Brii Bio Announces Strategic Partnership with Sinopharm to Advance Commercialization of Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China 2022-03-30 08:05
Everest Medicines Announces that Licensing Partner Pfizer Reports Positive Topline Results from Yearlong Phase 3 Trial of Etrasimod in Ulcerative Colitis Patients, Underscoring Best-in-Class Potential 2022-03-30 08:00
Innovent Announced 2021 Annual Results 2022-03-30 08:00
Daewoong Pharmaceutical submitted NDA for its global new drug Fexuclue Tablets to the Philippines 2022-03-29 09:00
Innovent Announces First Patient Dosing of Claudin18.2/CD3 Bispecific Antibody IBI389 in Phase 1a/1b Clinical Trial for Advanced Solid Tumor 2022-03-29 08:10
Telix and Xiel Sign U.K. and Ireland Distribution Agreement for Illuccix® 2022-03-29 07:39
Everest Medicines Announces Financial Results for Full Year Ended December 31, 2021 2022-03-29 06:30
Viva Biotech Announced 2021 Annual Results: Revenue Increased by 201.9% YoY, CRO Business Revenue Maintained Rapid Growth with an Increase of 68.7% 2022-03-29 01:01
Biocytogen Expands Global Footprint with the Opening of Biocytogen Europe Innovation Center in Germany 2022-03-28 21:30
Hyperflex® Balloon Catheter by Endovastec™ Receives Marketing Approval in Japan 2022-03-28 12:29
Innovent and Lilly Expand Strategic Partnership in Oncology 2022-03-28 08:00
Ascletis Announces the Latest Results of the Preclinical Studies of Two Novel Anti-Cancer Drug Candidates, ASC61 and ASC60, to be presented at AACR Annual Meeting 2022 2022-03-27 18:30
Henlius Receives NMPA Approval for its First Innovative Monoclonal Antibody HANSIZHUANG 2022-03-25 21:24
Abcam the most awarded company at 2022 industry awards 2022-03-25 20:40
Modern Chinese Medicine Announces Year 2021 Annual Results 2022-03-25 10:39
Insilico Medicine Announces Strategic Collaboration with EQRx to Jointly Advance AI-driven Drug Discovery, Development and Commercialization for Multiple Targets 2022-03-24 21:00
Huma and AstraZeneca Partner to Accelerate Innovation for Digital-First Patient Care 2022-03-24 07:00
Fosun International Announces 2021 Annual Results: Total Revenue Increased by 18% to RMB161.29 Billion, Striving to Pursue Steady and Sustainable Development 2022-03-23 23:01
Telix Advances Development of Glioblastoma Therapy Program 2022-03-23 10:16
Novavax and Serum Institute of India Announce First Emergency Use Authorization of Novavax' COVID-19 Vaccine in Adolescents ≥12 to <18 in India 2022-03-23 09:31
1 82 83 84 85 86 229